SEC Form D · Amendment · filed December 22, 2022
Venatorx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Christopher J. Burns · Malvern, PAExec · DirectorTimothy J. Henkel · Malvern, PAExecAnthony J. Meehan · Malvern, PAExecTimothy J. Haines · Malvern, PADirectorEzra J. Felker · Malvern, PAExecMartin J. Heidecker · Malvern, PADirectorMichael C. Diem · Malvern, PADirectorSergei J. Petukhov · Malvern, PADirectorDaniel C. Pevear · Malvern, PAExecSteven H. Rosenzweig · Great Neck, NYDirectorAndrew Firman · Dallas, TXDirectorPromus Equity Partners, LLC · Chicago, ILDirectorIsaac H. Kalish · Great Neck, NYExecWyatt Cavalier · Wilmington, DEExec · DirectorMatthew H. Gould · Great Neck, NYExecKim A. Bertolini · Denver, CODirectorJeffrey H. Gould · Great Neck, NYExecBenjamin H. Bolanos · Great Neck, NYExecMatt M. Whelan · Long Island City, NYDirectorDavid M. Langer · Long Island City, NYExec · DirectorJohn Evans Jr · Wesley Chapel, FLDirectorO'Meara Lauren · Franklin, TNExecOrin Wolf · NEW YORK, NYExecArabella FCRE Management, LLC · Alpharetta, GAExecJeff J. Seavey · Houston, TXDirectorJohn Uhlein · New York, NYExecDaniel Malooly · Newark, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗